Palmitic Acid Modulates Microglial Cell Response to Metabolic Endotoxemia in an In Vitro Study.
inflammation
metabolic endotoxemia
microglial cells
oxidative stress
palmitic acid
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
05 Aug 2023
05 Aug 2023
Historique:
received:
24
06
2023
revised:
03
08
2023
accepted:
03
08
2023
medline:
14
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Metabolic endotoxemia (ME) is characterized by a 2-3-fold increase in blood endotoxin levels and low-grade systemic inflammation without apparent infection. ME is usually accompanied by metabolic syndrome, characterized by central obesity and hyperlipidemia. According to numerous studies, ME may lead to functional brain disorders, including cognitive decline, depression, and dementia. In the current in vitro study, we aimed to determine the direct and indirect impact of endotoxin (LPS) and palmitic acid (PA), representing saturated fatty acids, on the inflammatory and oxidative stress response in the human microglial HMC3 cells unstimulated and stimulated with IFNγ. The study's results revealed that direct HMC3 cell exposition to endotoxin and PA increased inflammatory response measured as levels of IL-6 and MCP-1 released into the medium and PGE2 levels in cell lysates. Moreover, direct HMC3 cell treatment with PA and LPS induced oxidative stress, i.e., ROS and COX-2 production and lipid peroxidation. On the contrary, an indirect effect of LPS and PA on microglial cells, assessed as the impact of macrophage metabolites, was much lower regarding the inflammatory response, although still associated with oxidative stress. Interestingly, IFNγ had a protective effect on microglial cells, reducing the production of pro-inflammatory mediators and oxidative stress in HMC3 cells treated directly and indirectly with LPS and PA.
Identifiants
pubmed: 37571401
pii: nu15153463
doi: 10.3390/nu15153463
pmc: PMC10421407
pii:
doi:
Substances chimiques
Palmitic Acid
2V16EO95H1
Lipopolysaccharides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Neuron. 2015 Jan 21;85(2):296-302
pubmed: 25611508
Front Neurosci. 2018 Aug 06;12:552
pubmed: 30127714
Diabetes. 2010 Sep;59(9):2171-7
pubmed: 20566663
J Lipid Res. 2009 Jan;50(1):90-7
pubmed: 18815435
AAPS J. 2017 Jul;19(4):921-930
pubmed: 28397097
Front Neurosci. 2015 Aug 18;9:287
pubmed: 26347600
Neuroscience. 2020 Nov 1;447:15-27
pubmed: 31689488
Front Cell Neurosci. 2018 Jul 24;12:215
pubmed: 30087595
Cytokine. 2021 Aug;144:155582
pubmed: 34058569
Int Immunopharmacol. 2021 Dec;101(Pt B):107598
pubmed: 34233864
J Neuroinflammation. 2019 Sep 13;16(1):180
pubmed: 31519175
Int J Mol Sci. 2022 Feb 25;23(5):
pubmed: 35269720
J Intern Med. 2007 Dec;262(6):643-50
pubmed: 17986201
Sci Rep. 2018 Jan 19;8(1):1280
pubmed: 29352259
Neuron. 2013 Jan 9;77(1):10-8
pubmed: 23312512
Am J Clin Nutr. 2009 Feb;89(2):601-7
pubmed: 19073790
Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):E5038-47
pubmed: 26305941
Inflammation. 2021 Dec;44(6):2143-2150
pubmed: 34291398
Mol Psychiatry. 2021 Aug;26(8):3672-3683
pubmed: 32873895
Am J Physiol Cell Physiol. 2018 May 1;314(5):C545-C553
pubmed: 29384693
Int Immunopharmacol. 2016 Apr;33:18-23
pubmed: 26851629
Brain Behav Immun. 2016 Jan;51:230-239
pubmed: 26336035
PLoS One. 2016 Jun 10;11(6):e0157240
pubmed: 27285386
Arch Intern Med. 1989 Jul;149(7):1514-20
pubmed: 2662932
Curr Opin Toxicol. 2018 Feb;7:81-86
pubmed: 29862377
Clin Chem. 1995 Dec;41(12 Pt 2):1819-28
pubmed: 7497639
Lipids Health Dis. 2019 Mar 25;18(1):71
pubmed: 30909920
Nutrients. 2019 Sep 23;11(10):
pubmed: 31547555
Neurobiol Aging. 2014 Sep;35 Suppl 2:S59-64
pubmed: 24970568
Gastroenterology. 2012 May;142(5):1100-1101.e2
pubmed: 22326433
Biochimie. 2016 May;124:11-20
pubmed: 26133659
Genes Immun. 2005 Dec;6(8):712-9
pubmed: 16163375
Front Cell Dev Biol. 2021 Mar 19;9:651021
pubmed: 33816502
J Neurochem. 2007 Jun;101(5):1205-13
pubmed: 17403030
Exp Ther Med. 2019 Nov;18(5):3461-3469
pubmed: 31602221
Neurosci Lett. 2019 Apr 17;698:51-57
pubmed: 30615977
Prog Lipid Res. 2022 Jan;85:101144
pubmed: 34915080
Int J Nanomedicine. 2017 Dec 20;13:63-76
pubmed: 29317816
Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):
pubmed: 28716890
J Neurochem. 2003 Dec;87(5):1193-203
pubmed: 14622099
Diabetes. 2007 Jul;56(7):1761-72
pubmed: 17456850
Lipids Health Dis. 2021 Jul 7;20(1):65
pubmed: 34233682
Epidemiol Rev. 2013;35:22-32
pubmed: 23258415
Compr Psychoneuroendocrinol. 2021 Mar 17;6:100048
pubmed: 35757363
Int J Biol Sci. 2012;8(9):1254-66
pubmed: 23136554
Chronic Stress (Thousand Oaks). 2022 Feb 8;6:24705470221076390
pubmed: 35155966
Neurobiol Aging. 2005 Dec;26 Suppl 1:46-9
pubmed: 16219391
Diabetes. 2023 Feb 1;72(2):233-244
pubmed: 36318114
Front Oncol. 2023 Jan 27;13:1099811
pubmed: 36776289
Psychosom Med. 2015 Jul-Aug;77(6):697-709
pubmed: 26107577
Mol Neurobiol. 2022 Apr;59(4):2348-2362
pubmed: 35079937
Nat Commun. 2019 Dec 20;10(1):5816
pubmed: 31862977
J Neurochem. 2005 Mar;92(5):997-1009
pubmed: 15715651
Neuropharmacology. 2015 Sep;96(Pt A):42-54
pubmed: 25445486
Altern Ther Health Med. 2017 Jul;23(4):42-54
pubmed: 28646814
Semin Immunopathol. 2013 Sep;35(5):601-12
pubmed: 23732506
J Pharmacol Exp Ther. 2003 Jan;304(1):319-25
pubmed: 12490607
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
J Nutr Biochem. 2011 Jan;22(1):53-9
pubmed: 20303729
Nutrients. 2019 Aug 13;11(8):
pubmed: 31412673
Biomedicines. 2022 Feb 10;10(2):
pubmed: 35203628
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2506-10
pubmed: 2320571
Front Neurosci. 2019 Mar 26;13:265
pubmed: 30983955
Metab Syndr Relat Disord. 2018 Sep;16(7):321-328
pubmed: 29957105
J Nutr Biochem. 2012 Oct;23(10):1214-23
pubmed: 22209004
Front Endocrinol (Lausanne). 2017 Apr 04;8:60
pubmed: 28421037
Front Physiol. 2021 Mar 30;12:645646
pubmed: 33868013
J Neuroinflammation. 2020 Mar 24;17(1):93
pubmed: 32209097
J Mol Neurosci. 2022 Sep;72(9):1929-1951
pubmed: 35821178
Sci Rep. 2018 Oct 23;8(1):15648
pubmed: 30353127